Stay updated on Daratumumab for AML/High-Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for AML/High-Risk MDS Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now includes new user-help sections (No longer looking for participants; How to Read a Study Record; Common Questions; How to Join a Study) and a new revision tag (Revision: v3.6.0). The older label 'Intervention / Treatment' and the earlier revision tag (Revision: v3.5.5) were removed.
    Difference
    0.6%
    Check dated 2026-06-13T01:20:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The revision label on the study record was updated from v3.5.4 to v3.5.5, signaling a new version of the study entry. This reflects a minor update to the record rather than substantive changes to the study design, eligibility criteria, or outcome measures.
    Difference
    0.1%
    Check dated 2026-06-05T22:45:16.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a minor update to the document history. This change does not modify study details or content.
    Difference
    0.1%
    Check dated 2026-05-15T14:30:28.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page’s displayed revision/version has been bumped from v3.5.2 to v3.5.3, indicating a website/app release rather than an update to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:16.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:34.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:00:56.000Z thumbnail image

Stay in the know with updates to Daratumumab for AML/High-Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.